Micronutrition for the Weight Loss Surgery Patient
The level of support varies by plan
For those who do discontinue, maintaining weight loss requires aggressive lifestyle strategies: high protein intake (1.01.6 g per kg of body weight daily), consistent resistance training, and ongoing monitoring
4e), and GLP-1RA/tesaglitazar further improved glucose tolerance relative to mice treated with vehicle or GLP-1RA (Fig
They typically appear mild, intermittent, and resolve without intervention
In summary, based on preclinical and clinical studies, the addition of a dual GLP-1/GIP receptor agonist like CT-868 to insulin therapy for the treatment of T1D in patients with overweight or obesity could offer significant benefits in terms of improved glycemic control, reduced insulin doses, and weight loss, while also likely having a favorable safety and tolerability profile due to its intentional signaling bias